Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

Overview of attention for article published in Leukemia, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter: 48 X users
patent: 3 patents

facebook: 1 Facebook page

Readers on

mendeley: 63 Mendeley

So far, Altmetric has seen 76 X posts from 48 X users, with an upper bound of 66,395 followers.

@DrBaderAlanazi1 @nami_arise Thanks Bader. All started from your original investigations . https://t.co/dxsAz8Dx8H

@PMMC_t الدكتور بدر أحد المميزين السعوديين الشباب الذين تركوا بصمة خلال ابتعاثهم. ويعمل مع فريق متميز ومبدع من جامعة كاردف هنا البحث المنشور https://t.co/L167TK1hsT

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. https://t.co/sHk8ivqzB2

RT @alex_tonks: 👏🙌👏 to Bader Alanazi, 1st author on this publication https://t.co/dxsAz8Dx8H but today he successfully defended his thesis.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 72 additional X posts.